This study, sponsored by Boston Scientific, is a prospective, multi-center, global registry of Boston Scientific neurostimulation systems for pain. The endpoints of this registry are intended to provide a broad evidence base to assess long-term clinical and economic outcomes of BSC neurostimulation systems in a large number of subjects representing real-world use patterns. The registry will also bridge the existing evidence gap in disease management, treatment effectiveness, health economic value, and patient outcomes for on-label use of the systems.
Primary Investigator:Shakil Ahmed, M.B. B.S.
Status:Open to Enrollment